Immix Biopharma (IMMX) director Jane Buchan awarded RSUs and 12,500 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Immix Biopharma director Jane Buchan reported equity compensation awards. She received 6,250 restricted stock units of common stock, bringing her direct common stock holdings to 28,705 shares after the grant.
She was also granted options to buy 12,500 shares of common stock at an exercise price of $8.78 per share, expiring on May 22, 2036. The RSUs vest in full on the earlier of one year from grant or the 2027 annual meeting, while the options vest in substantially equal monthly installments over 12 months, with any remaining portion vesting at the 2027 annual meeting, in each case subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
BUCHAN JANE
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 12,500 | $0.00 | -- |
| Grant/Award | Common Stock | 6,250 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 12,500 shares (Direct, null);
Common Stock — 28,705 shares (Direct, null)
Footnotes (1)
- The Reporting Person was granted 6,250 restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting") is held, subject to the Reporting Person's continued service with the Issuer. The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date.
Key Figures
RSU grant: 6,250 RSUs
Common shares held: 28,705 shares
Stock options granted: 12,500 options
+2 more
5 metrics
RSU grant
6,250 RSUs
Restricted stock units granted on May 22, 2026
Common shares held
28,705 shares
Direct common stock holdings after RSU grant
Stock options granted
12,500 options
Options on common stock granted on May 22, 2026
Option exercise price
$8.78 per share
Conversion or exercise price for stock options
Option expiration
May 22, 2036
Expiration date of stock option grant
Key Terms
restricted stock units, 2021 Equity Incentive Plan, stock option, vest, +1 more
5 terms
restricted stock units financial
"The Reporting Person was granted 6,250 restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2021 Equity Incentive Plan financial
"granted 6,250 restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan"
stock option financial
"The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest financial
"RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"the date that the Issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting") is held"
FAQ
What did Immix Biopharma (IMMX) director Jane Buchan receive in this Form 4 filing?
Jane Buchan received equity compensation consisting of 6,250 restricted stock units and stock options for 12,500 shares of Immix Biopharma common stock. These awards increase her equity stake and align her incentives with shareholders through time-based vesting tied to continued service.
What are the key terms of Jane Buchan’s Immix Biopharma (IMMX) stock option grant?
Jane Buchan received options to purchase 12,500 shares of Immix Biopharma common stock at an exercise price of $8.78 per share. The options expire on May 22, 2036 and vest in substantially equal monthly installments over 12 months, subject to continued board service.
How do Jane Buchan’s Immix Biopharma (IMMX) RSUs vest?
Her 6,250 restricted stock units vest in full on the earlier of the one-year anniversary of the grant date or the date of Immix Biopharma’s 2027 annual meeting of stockholders. Vesting requires her continued service with the company through the applicable vesting date.
Are Jane Buchan’s Immix Biopharma (IMMX) equity awards tied to the 2027 annual meeting?
Yes. The RSUs vest on the earlier of one year from grant or the 2027 annual meeting, and any unvested stock options vest if the 2027 annual meeting occurs before the first anniversary. Both awards remain subject to her continued service on the board.